National Parkinson's Foundation

A Single-Dose Placebo-Controlled Study of AMG 162, a Fully Human Monoclonal Antibody to RANKL, in Postmenopausal Women

Pirow Bekker, Donna Holloway, Amy S Rasmussen et al. · Journal of Bone and Mineral Research · 2004 · 761 citations · Full text

Pharmacokinetics and Pharmacodynamic Effects of the Oral DPP‐4 Inhibitor Sitagliptin in Middle‐Aged Obese Subjects

Gary Herman, Arthur Bergman, Fang Liu et al. · The Journal of Clinical Pharmacology · 2006 · 184 citations

Middle‐aged Obese Subjects, Pharmacotherapy, Insulin Signaling +16

A Single-Dose Placebo-Controlled Study of AMG 162, a Fully Human Monoclonal Antibody to RANKL, in Postmenopausal Women

Pirow Bekker, Donna Holloway, Amy S Rasmussen et al. · Journal of Bone and Mineral Research · 2005 · 97 citations

Single-dose Placebo-controlled Study, Amg 162, Immunology +24

Pharmacokinetics of insulin aspart in obesity, renal impairment, or hepatic impairment

Gregory B. Holmes, Lawrence Galitz, Peter Hu et al. · British Journal of Clinical Pharmacology · 2005 · 85 citations · Full text

Pharmacokinetics of Sirolimus (Rapamycin) in Subjects With Mild to Moderate Hepatic Impairment

James J. Zimmerman, Kenneth C. Lasseter, Heng‐Keang Lim et al. · The Journal of Clinical Pharmacology · 2005 · 38 citations

Sirolimus Cl/f, Immunology, Moderate Hepatic Impairment +18